DK1306082T3 - Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer - Google Patents

Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer

Info

Publication number
DK1306082T3
DK1306082T3 DK02026980T DK02026980T DK1306082T3 DK 1306082 T3 DK1306082 T3 DK 1306082T3 DK 02026980 T DK02026980 T DK 02026980T DK 02026980 T DK02026980 T DK 02026980T DK 1306082 T3 DK1306082 T3 DK 1306082T3
Authority
DK
Denmark
Prior art keywords
under pressure
metered dose
aerosol formulations
dose inhalers
pharmaceutical aerosol
Prior art date
Application number
DK02026980T
Other languages
Danish (da)
English (en)
Inventor
Frank E Blondino
Michael Brucato
Maria W Buenafe
Original Assignee
Ivax Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ivax Research Inc filed Critical Ivax Research Inc
Application granted granted Critical
Publication of DK1306082T3 publication Critical patent/DK1306082T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK02026980T 1998-06-19 1999-06-18 Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer DK1306082T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/099,779 US6451285B2 (en) 1998-06-19 1998-06-19 Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
PCT/US1999/013863 WO1999065460A2 (fr) 1998-06-19 1999-06-18 Inhalateurs doseurs sous pression et formulations pharmaceutiques pour aerosols

Publications (1)

Publication Number Publication Date
DK1306082T3 true DK1306082T3 (da) 2004-06-01

Family

ID=22276581

Family Applications (2)

Application Number Title Priority Date Filing Date
DK99931837T DK1085856T3 (da) 1998-06-19 1999-06-18 Tryksatte inhalatorer med afmålt dosis og farmaceutiske aerosolformuleringer, der omfatter en beta-agonist
DK02026980T DK1306082T3 (da) 1998-06-19 1999-06-18 Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DK99931837T DK1085856T3 (da) 1998-06-19 1999-06-18 Tryksatte inhalatorer med afmålt dosis og farmaceutiske aerosolformuleringer, der omfatter en beta-agonist

Country Status (23)

Country Link
US (2) US6451285B2 (fr)
EP (2) EP1306082B1 (fr)
JP (1) JP2002518100A (fr)
KR (1) KR20010053025A (fr)
CN (2) CN1154477C (fr)
AR (1) AR018891A1 (fr)
AT (2) ATE250409T1 (fr)
AU (1) AU762927B2 (fr)
BR (1) BR9912170A (fr)
CA (1) CA2335303A1 (fr)
CO (1) CO5031245A1 (fr)
DE (2) DE69911602T2 (fr)
DK (2) DK1085856T3 (fr)
ES (2) ES2205848T3 (fr)
HU (1) HUP0102468A3 (fr)
IL (1) IL140340A0 (fr)
NO (1) NO20006466L (fr)
PL (1) PL345399A1 (fr)
PT (2) PT1306082E (fr)
RU (1) RU2214230C2 (fr)
SK (1) SK19442000A3 (fr)
WO (1) WO1999065460A2 (fr)
ZA (1) ZA200007455B (fr)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) * 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
US6315985B1 (en) * 1999-06-18 2001-11-13 3M Innovative Properties Company C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
IT1317720B1 (it) * 2000-01-07 2003-07-15 Chiesi Farma Spa Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
CZ303833B6 (cs) 2000-05-22 2013-05-22 Chiesi Farmaceutici S.P.A. Aerosolový prostredek
US20060257324A1 (en) 2000-05-22 2006-11-16 Chiesi Farmaceutici S.P.A. Pharmaceutical solution formulations for pressurised metered dose inhalers
US20030072717A1 (en) * 2001-02-23 2003-04-17 Vapotronics, Inc. Inhalation device having an optimized air flow path
RU2294737C2 (ru) * 2001-03-30 2007-03-10 Яготек Аг Медицинские аэрозольные составы
DE60103527T2 (de) * 2001-07-02 2005-06-16 Chiesi Farmaceutici S.P.A. Optimierte Tobramycin-Formulierung zur Aerosolbildung
US20030178022A1 (en) * 2001-12-21 2003-09-25 Chiesi Farmaceutici S.P.A. Pressurized metered dose inhaler (PMDI) actuators and medicinal aerosol solution formulation products comprising therse actuators
DE10205087A1 (de) * 2002-02-07 2003-08-21 Pharmatech Gmbh Cyclodextrine als Suspensionsstabilisatoren in druckverflüssigten Treibmitteln
MXPA04008372A (es) * 2002-03-01 2004-11-26 Chiesi Farma Spa Formulacion superfina de formoterol.
GB0207899D0 (en) * 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and cielesonide aerosol formulations
GB0219511D0 (en) * 2002-08-21 2002-10-02 Norton Healthcare Ltd Method of preparing dry powder inhalation compositions
KR101369631B1 (ko) * 2002-08-21 2014-03-05 노턴 헬스케어 리미티드 흡입용 조성물
US20050158248A1 (en) * 2002-08-21 2005-07-21 Xian-Ming Zeng Method of preparing dry powder inhalation compositions
GB0323685D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
GB0323684D0 (en) * 2003-10-09 2003-11-12 Jagotec Ag Improvements in or relating to organic compounds
EP1595531A1 (fr) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Formulation d'une solution pharmaceutique stable pour aérosols doseurs sous pression
WO2007008427A2 (fr) * 2005-07-08 2007-01-18 Xemplar Pharmaceuticals, Llc Compositions aerosol et procedes
US8367734B1 (en) 2005-08-11 2013-02-05 Amphastar Pharmaceuticals Inc. Stable epinephrine suspension formulation with high inhalation delivery efficiency
US8815258B2 (en) 2009-05-29 2014-08-26 Pearl Therapeutics, Inc. Compositions, methods and systems for respiratory delivery of two or more active agents
AU2010253776B2 (en) * 2009-05-29 2015-01-22 Pearl Therapeutics, Inc. Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems
GB0918149D0 (en) 2009-10-16 2009-12-02 Jagotec Ag Improved medicinal aerosol formulation
EP3020393B1 (fr) 2009-12-16 2020-10-07 3M Innovative Properties Company Formulations et procédés de commande de distribution granulométrique mdi
GB201108039D0 (en) 2011-05-13 2011-06-29 Mexichem Amanco Holding Sa Compositions
GB201117619D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
GB201117621D0 (en) 2011-10-12 2011-11-23 Mexichem Amanco Holding Sa Compositions
WO2014144894A1 (fr) 2013-03-15 2014-09-18 Pearl Therapeutics, Inc. Procedes et systemes de conditionnement de matieres cristallines particulaires
GB201306984D0 (en) 2013-04-17 2013-05-29 Mexichem Amanco Holding Sa Composition
BR112018011266B1 (pt) 2015-12-04 2023-11-21 Mexichem Fluor S.A. De C.V. Composição farmacêutica, recipiente vedado, e, métodos para tratar um paciente que sofre ou é propenso a sofrer de um distúrbio respiratório e para estabilizar uma composição farmacêutica
JP6781830B2 (ja) 2016-09-19 2020-11-04 メキシケム フロー エセ・ア・デ・セ・ヴェ 医薬組成物
JP6781828B2 (ja) 2016-09-19 2020-11-04 メキシケム フロー エセ・ア・デ・セ・ヴェ 医薬組成物
ES2957459T3 (es) 2016-09-19 2024-01-19 Mexichem Fluor Sa De Cv Composición farmacéutica que comprende glicopirrolato
CN109464429B (zh) * 2018-12-13 2021-04-27 上海方予健康医药科技有限公司 一种吸入压力定量气雾剂药物组合物及其制备方法

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE556587A (fr) 1957-01-31 1957-04-11
NL7708731A (nl) 1976-08-13 1978-02-15 Montedison Spa Werkwijze voor de bereiding van nieuwe drijf- middelsamenstellingen voor aerosolen.
US5225183A (en) 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
US5766573A (en) * 1988-12-06 1998-06-16 Riker Laboratories, Inc. Medicinal aerosol formulations
IE67185B1 (en) 1990-02-02 1996-03-06 Fisons Plc Propellant compositions
AU8055691A (en) 1990-06-29 1992-01-23 Fisons Plc Pressurised aerosol compositions
DE69105212T2 (de) 1990-10-18 1995-03-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzubereitung, die beclometason 17,21-dipropionat enthält.
MX9203481A (es) 1990-10-18 1992-07-01 Minnesota Mining & Mfg Formulaciones.
US5190029A (en) 1991-02-14 1993-03-02 Virginia Commonwealth University Formulation for delivery of drugs by metered dose inhalers with reduced or no chlorofluorocarbon content
EP0504112A3 (en) 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
WO1992022286A1 (fr) 1991-06-12 1992-12-23 Minnesota Mining And Manufacturing Company Formulations pour aerosol en suspension comprenant du sulfate d'albuterol
DE4123663A1 (de) 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
US5736124A (en) * 1991-12-12 1998-04-07 Glaxo Group Limited Aerosol formulations containing P134a and particulate medicament
AU663906B2 (en) * 1991-12-12 1995-10-26 Glaxo Group Limited Medicaments
DE69218455T2 (de) 1991-12-18 1997-10-23 Minnesota Mining And Mfg. Co., Saint Paul, Minn. Aerosolzusammensetzungen für arzneimittelsuspensionen
WO1993011773A1 (fr) 1991-12-18 1993-06-24 Aktiebolaget Astra Nouvelle combinaison de formoterol et de budesonide
DE59206234D1 (de) 1991-12-31 1996-06-13 Hoechst Ag Medizinische Aerosolformulierung
US5492688A (en) 1993-04-28 1996-02-20 The Center For Innovative Technology Metered dose inhaler fomulations which include the ozone-friendly propellant HFC 134a and a pharmaceutically acceptable suspending, solubilizing, wetting, emulsifying or lubricating agent
US5508023A (en) 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
EE9700138A (et) 1994-12-22 1997-12-15 Astra Aktiebolag Aerosoolravimvormid
DE4446891A1 (de) * 1994-12-27 1996-07-04 Falk Pharma Gmbh Stabile wäßrige Budesonid-Lösung
GB9612297D0 (en) 1996-06-11 1996-08-14 Minnesota Mining & Mfg Medicinal aerosol formulations
GB9616237D0 (en) * 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6039932A (en) * 1996-09-27 2000-03-21 3M Innovative Properties Company Medicinal inhalation aerosol formulations containing budesonide
SE9603669D0 (sv) 1996-10-08 1996-10-08 Astra Ab New combination
IES80485B2 (en) 1996-12-04 1998-08-12 Bioglan Ireland R & D Ltd Pharmaceutical compositions and devices for their administration
US6451285B2 (en) * 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol

Also Published As

Publication number Publication date
AU4825999A (en) 2000-01-05
HUP0102468A3 (en) 2002-12-28
NO20006466L (no) 2001-02-16
NO20006466D0 (no) 2000-12-18
DK1085856T3 (da) 2003-12-08
ATE260093T1 (de) 2004-03-15
KR20010053025A (ko) 2001-06-25
ZA200007455B (en) 2002-06-13
EP1306082B1 (fr) 2004-02-25
WO1999065460A2 (fr) 1999-12-23
JP2002518100A (ja) 2002-06-25
PL345399A1 (en) 2001-12-17
AR018891A1 (es) 2001-12-12
PT1085856E (pt) 2004-01-30
PT1306082E (pt) 2004-05-31
ATE250409T1 (de) 2003-10-15
DE69915144D1 (de) 2004-04-01
DE69915144T2 (de) 2004-12-09
RU2214230C2 (ru) 2003-10-20
SK19442000A3 (sk) 2001-09-11
US6451285B2 (en) 2002-09-17
EP1085856B1 (fr) 2003-09-24
AU762927B2 (en) 2003-07-10
CN1310611A (zh) 2001-08-29
CA2335303A1 (fr) 1999-12-23
US20020018753A1 (en) 2002-02-14
BR9912170A (pt) 2001-10-23
CN1522692A (zh) 2004-08-25
ES2215153T3 (es) 2004-10-01
CO5031245A1 (es) 2001-04-27
HUP0102468A2 (hu) 2002-03-28
EP1085856A2 (fr) 2001-03-28
DE69911602D1 (de) 2003-10-30
US20030077230A1 (en) 2003-04-24
ES2205848T3 (es) 2004-05-01
DE69911602T2 (de) 2004-07-01
WO1999065460A3 (fr) 2000-04-27
IL140340A0 (en) 2002-02-10
CN1154477C (zh) 2004-06-23
EP1306082A1 (fr) 2003-05-02

Similar Documents

Publication Publication Date Title
DK1306082T3 (da) Afmålte dosisinhalatorer under tryk og farmaceutiske aerosolformuleringer
HUS1800032I1 (hu) Gyógyászati célú stabil aeroszol összetétel, inhalátor az aeroszol pontos adagolásához és eljárás ennek feltöltésére
DE69929358D1 (de) Druckdosierinhalatoren
NO307864B1 (no) Farmasøytisk aerosolformulering, boks og doseringsinhalator
DK0883415T3 (da) Inhalator til pulverformigt medikament
PL348809A1 (en) Pharmaceutical aerosol formulations containing fluoroalkanes, budesonide and formoterol
ATE228823T1 (de) Pharmazeutische aerosolformulierung
ATE236617T1 (de) Aerosol-arzneiformulierungen
EE04451B1 (et) Pulberinhalaatori kapsel farmatseutiliste preparaatide mahutamiseks
DK0934057T3 (da) Medicinske aerosolformuleringer med formoterol
HUP0200066A3 (en) Pharmaceutical aerosol formulations containing fluoroalkanes and budesonide
NO20026055L (no) Farmasöytiske komponenter innbefattende humant paratyreoideahormon og farmasöytiske sammenstninger for nasal administrering inneholdendekomponentene